Found vs Noom: Which Weight Loss Platform Is Right for You

——————————————————————————–

Found and Noom compete in the medical weight loss space but with meaningfully different approaches. Found is built around clinical assessment with a broad medication formulary and lighter behavioral coaching. Noom is built around behavioral psychology with medication access available through Noom Med. The two platforms tend to attract different patients — Found patients usually want medication-driven weight loss with a strong clinical assessment, while Noom patients usually want behavioral support with optional medication. This found vs noom comparison breaks down 2026 pricing, the structural differences in approach, and which platform fits which patient profiles. The short version: Found for medical-first weight loss with a broader formulary; Noom for behavior-first weight loss with an optional medication add-on. Neither one replaces a conversation with your own clinician — think of both as a way to connect with prescribers and coaches, not as medical advice in an app.

Found vs Noom — pricing in 2026

Prices in this category change frequently, and both companies run promotions, tiered plans, and annual-prepay discounts. Treat the figures below as ballpark estimates and verify the current numbers on each platform before you sign up.

Found pricing (approximate, 2026):

• Membership: roughly $49/month when you have insurance that covers your medication, up to about $99–$149/month for self-pay brand-name plans
• Annual prepay: reduces the effective per-month membership cost
• Medication billed separately: generics can be modest (roughly $10–$30/month), while branded GLP-1s such as Wegovy or Zepbound purchased through manufacturer cash-pay channels run into the hundreds of dollars per month
• Optional one-on-one coaching at higher tiers

Noom pricing (approximate, 2026):

• Noom Weight (the behavioral app): sold on subscription, frequently discounted; annual plans have historically landed around $200/year, with shorter plans costing more per month
• Noom Med / GLP-1Rx (medication-included plans): tiered, commonly quoted in the roughly $150–$300/month range depending on the program and whether a lower-cost microdose option is chosen
• Medication cost may be bundled or billed separately depending on the plan

Because both companies restructure their plans often, the cleanest comparison is: Noom’s standalone behavioral app is usually the cheapest entry point, Found sits in the middle as a clinician-led membership plus medication, and Noom’s med-included bundles land in a similar all-in range to Found once medication is added. What you actually pay depends heavily on which products are bundled and what medication is prescribed. See our individual Found review and Noom Med review for current detail.

A note on GLP-1s and compounded medications

Both Found and Noom can connect patients with GLP-1 medications through their clinicians, and this is the part of the landscape that changed the most heading into 2026. During the 2022–2024 shortages, many telehealth platforms offered compounded semaglutide and tirzepatide as a lower-cost workaround. That window has largely closed. The FDA declared the semaglutide shortage resolved in February 2025 (tirzepatide came off the shortage list in December 2024), and through 2025 and into 2026 the agency moved to wind down mass compounding of these drugs and warned telehealth companies about marketing compounded versions as equivalent to the branded products.

The practical takeaway for readers comparing Found and Noom: reputable platforms now emphasize FDA-approved, brand-name GLP-1 products dispensed against a legitimate prescription, with the medication chosen and monitored by a prescriber. If any platform is still pitching cheap “compounded GLP-1” as a headline offer, treat that as a reason to ask questions rather than a bargain. Whether a GLP-1 is appropriate for you at all — and which one — is a clinical decision that belongs with a licensed clinician who reviews your full history.

Behavioral content — Noom’s clear strength

Noom’s core asset is its behavioral content. The cognitive-behavioral framing of food psychology, the calorie-density-based food categorization system, the daily lessons, and the structured behavior-change content are well developed. Noom has academic partnerships and published research backing the behavioral approach.

Found’s behavioral content is lighter. The platform offers app-based educational content covering nutrition, exercise, sleep, and emotional health, but it is not the platform’s centerpiece. For patients who want or need substantial behavioral support, Noom’s content is more developed.

Clinical depth and medication formulary — Found’s clear strength

Found’s clinical assessment is generally more comprehensive than Noom Med’s. The Found intake covers metabolic markers, hormonal factors, behavioral history, prior weight-loss attempts, and contraindications in some depth, with the assessment data informing medication selection from a broader formulary.

Found’s medication formulary is broader and may include:

• GLP-1 medications including Wegovy and Zepbound
• Metformin off-label for insulin resistance
• Bupropion (Wellbutrin) off-label, especially with comorbid depression
• Naltrexone, often combined with bupropion (Contrave)
• Topiramate off-label, often combined with phentermine (Qsymia)
• Other older weight-loss medications

Noom Med’s formulary is narrower, oriented primarily around GLP-1 medications. For patients with insulin resistance, mild obesity, or budget constraints where a non-GLP-1 medication would fit better, Found’s broader formulary can be meaningful. As always, whether any of these is appropriate is a prescriber’s call, not something to infer from a comparison table.

The “behavioral first” vs “medical first” question

The fundamental question between Found and Noom is whether you want behavioral support as the primary intervention with medication as a tool, or medical management as the primary intervention with behavioral support layered in.

Noom’s approach prioritizes behavioral change. The Noom app is the centerpiece; Noom Med is added when patients and their clinicians decide medication is appropriate. Patients who lose weight on the standard app alone may not need Noom Med at all. The framing is psychology-first.

Found’s approach prioritizes medical management. The clinical assessment drives the program, medication selection is matched to the patient’s profile, and behavioral content supports the medical intervention. The framing is clinical-first. Both approaches are legitimate; they fit different patients.

Engagement patterns and outcomes

Noom’s standard app tends to produce high engagement during the first 30–90 days followed by significant drop-off. Reported outcomes are strongly correlated with continued engagement — committed users often see real weight loss, while users who stop engaging within 90 days generally see less. Individual results vary widely.

Found’s outcomes track more with medication adherence and clinical engagement. In clinical trials of GLP-1 medications, patients who stay on treatment and engage with monitoring have lost roughly 10–15% of body weight over 12–18 months on average; results on older weight-loss medications are typically smaller (often in the 5–10% range). These are population averages from the drug literature, not a promise for any one person.

Specific use cases — when each platform tends to fit

Found may fit if: your primary goal is medical weight loss with a strong clinical assessment; you want broader medication options beyond GLP-1s; you have insulin resistance, budget constraints, or other factors making a non-GLP-1 medication worth discussing; and you do not need intensive behavioral coaching.

Noom (standard app) may fit if: you want behavior-first weight-loss support without medication; you are self-directed and will engage with daily app content; and you might add Noom Med later if you and a clinician decide that makes sense.

Noom + Noom Med may fit if: you are an existing Noom user who wants to add a GLP-1 with clinician oversight; you value the integration of behavioral content with medication; and you want month-to-month flexibility.

Consider other options if: you want intensive structured coaching. Calibrate‘s longer program with regular coaching provides more hands-on accountability than either Found or Noom for people who need it.

How both compare to Calibrate, Hims, and Ro

Compared to Calibrate, both Found and Noom are more flexible (monthly vs a longer commitment) but offer lighter coaching. Calibrate’s more intensive one-on-one coaching can be more impactful than Found’s lighter coaching or Noom’s app-based content for patients who need accountability.

Compared to Hims and Ro weight-loss programs, both Found and Noom generally offer more clinical or behavioral structure. Hims and Ro deliver primarily medication access with lighter wraparound; Found and Noom add a fuller clinical assessment (Found) or behavioral content (Noom). See our Calibrate vs Found and Noom vs Calibrate comparisons, and the broader telehealth guide for how these platforms fit the wider market.

Frequently Asked Questions

Is Noom or Found cheaper?

Noom’s standalone behavioral app is usually the cheapest entry point. Once medication is added, Noom’s med-included plans and Found’s membership-plus-medication land in a broadly similar all-in range. Because both change pricing often, verify the current numbers on each platform before deciding.

Which has better behavioral content?

Noom. The behavioral-psychology framing, daily lessons, and food-categorization system are more developed than Found’s behavioral content.

Which has better medication options?

Found tends to offer a broader formulary — GLP-1s plus metformin, bupropion, naltrexone, topiramate, and other older weight-loss drugs. Noom Med is oriented primarily around GLP-1 medications. Which medication (if any) is right for you is a clinician’s decision.

Can I use the standard Noom app with a different medical platform?

Yes. Some people use the standard Noom app for behavioral content alongside Found, Calibrate, or another medical weight-loss platform. There is no exclusivity.

Are compounded GLP-1s still available through these platforms?

Largely no. After the FDA declared the semaglutide and tirzepatide shortages resolved in 2024–2025, mass compounding of these drugs was wound down. Reputable platforms now focus on FDA-approved, prescribed brand-name GLP-1 products. Discuss any GLP-1 option with a licensed clinician.

The bottom line on Found vs Noom

Found and Noom occupy different positioning in weight loss. Found is medical-first, with a broader medication formulary and a stronger clinical assessment but lighter behavioral coaching. Noom is behavior-first, with stronger app content and optional medication via Noom Med. The right choice depends on whether you want medication-driven weight loss with clinical structure (Found) or behavior-driven weight loss with optional medication (Noom). Some people combine the standard Noom app for behavioral content with Found or another medical platform for clinical management — which can be more cost-effective than a bundled med-included plan. Whatever you choose, the medication and dosing decisions belong with a licensed clinician who knows your history.